Ondansetron Tablet, Orally Disintegrating
Product Images NDC 16714-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 16714-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

NDC 16714-200-30 is a medication containing Ondansetron Orally Disintegrating Tablets, USP. It comes in a pack of 30 tablets (3 blister cards each containing 10 tablets). The medication is intended for the treatment of nausea and vomiting after chemotherapy, radiation therapy, and surgery. Dosage instructions are not provided. Copyright 2005 Nrastar Hetcar Hotings Inc.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

This is a description for Ondansetron Orally Disintegrating Tablets, USP used to prevent nausea. The tablets are packaged into 3 blister cards, each containing 10 tablets. The medication contains 8mg Ondansetron USP, and each tablet has 37mg of shayan. The pack also contains basic instructions for usage, including dosage recommendations and warnings for storage and dispensing. The manufacturer is Norstar Healthcare Holdings, and the pack is labelled with NDC 16714-201-30.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.